Movatterモバイル変換


[0]ホーム

URL:


GR73843B - - Google Patents

Info

Publication number
GR73843B
GR73843BGR63828AGR810163828AGR73843BGR 73843 BGR73843 BGR 73843BGR 63828 AGR63828 AGR 63828AGR 810163828 AGR810163828 AGR 810163828AGR 73843 BGR73843 BGR 73843B
Authority
GR
Greece
Application number
GR63828A
Other languages
Greek (el)
Inventor
James Michael Dunn
John Francis Lampard
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453external-prioritypatent/US4308251A/en
Application filed by Boots Co PlcfiledCriticalBoots Co Plc
Publication of GR73843BpublicationCriticalpatent/GR73843B/el

Links

Classifications

Landscapes

GR63828A1980-01-111981-01-09GR73843B (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US11143080A1980-01-111980-01-11
US06/194,453US4308251A (en)1980-01-111980-10-17Controlled release formulations of orally-active medicaments

Publications (1)

Publication NumberPublication Date
GR73843Btrue GR73843B (en)1984-05-07

Family

ID=26808896

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GR63828AGR73843B (en)1980-01-111981-01-09

Country Status (22)

CountryLink
JP (1)JPS56103110A (en)
AT (1)AT374681B (en)
AU (1)AU542824B2 (en)
BE (1)BE886998A (en)
CA (1)CA1140466A (en)
CH (1)CH646604A5 (en)
DE (1)DE3100191A1 (en)
DK (1)DK6181A (en)
ES (2)ES498369A0 (en)
FI (1)FI76927C (en)
FR (1)FR2473308B1 (en)
GB (1)GB2067072B (en)
GR (1)GR73843B (en)
IE (1)IE50806B1 (en)
IN (1)IN151913B (en)
IT (1)IT1221041B (en)
LU (1)LU83052A1 (en)
NL (1)NL8100037A (en)
NO (1)NO156153C (en)
NZ (1)NZ195933A (en)
SE (1)SE447450B (en)
ZA (1)ZA81136B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2496082A (en)*1947-05-241950-01-31Ashenfelter WilliamScaffold structure
IT1144911B (en)*1981-03-191986-10-29Pharmatec Spa CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN
JPS59227817A (en)*1983-06-071984-12-21Toyo Jozo Co Ltd Long-acting oral Bredenine preparation
JPH0662404B2 (en)*1983-06-141994-08-17シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド Controlled-release naproxen and naproxen sodium tablets
ZA836030B (en)*1983-08-161985-02-27Verex LabConstant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en)*1983-08-161985-02-27Verex LabConstant release rate solid dosage theophylline formulation
US4774091A (en)*1983-10-141988-09-27Sumitomo Pharmaceuticals Company, Ltd.Long-term sustained-release preparation
US4855134A (en)*1983-10-141989-08-08Sumitomo Pharmaceuticals Company, LimitedSustained-release preparation
US5385738A (en)*1983-10-141995-01-31Sumitomo Pharmaceuticals Company, Ltd.Sustained-release injection
EP0138216B1 (en)*1983-10-141993-01-07Sumitomo Pharmaceuticals Company, LimitedSustained-release ifn preparation for parenteral administration
ATE87469T1 (en)*1985-12-271993-04-15Sumitomo Pharma PROCESS FOR THE MANUFACTURE OF A DELAYED RELEASE FORMULATION.
GB8601204D0 (en)*1986-01-181986-02-19Boots Co PlcTherapeutic agents
US4968508A (en)*1987-02-271990-11-06Eli Lilly And CompanySustained release matrix
ZA881301B (en)*1987-02-271989-10-25Lilly Co EliSustained release matrix formulations
WO1997002019A1 (en)*1995-06-301997-01-23Baylor UniversityPolyester/carboxylic acid composite materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2953497A (en)*1953-06-031960-09-20Howard A PressTherapeutic tablets
BE604564A (en)*1960-06-06
US3577514A (en)*1968-06-101971-05-04PfizerSustained release pharmaceutical tablets
US3773920A (en)*1971-07-141973-11-20Nikken Chemicals Co LtdSustained release medicinal composition
US3906086A (en)*1971-07-191975-09-16Richard G PowersTimed-release aspirin
GB1500300A (en)*1975-01-061978-02-08Ciba Geigy AgPharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en)*1977-06-241979-01-27Shin Etsu Chem Co LtdDisintegratable granule

Also Published As

Publication numberPublication date
CA1140466A (en)1983-02-01
SE8100104L (en)1981-07-12
NO156153C (en)1987-08-05
ES509179A0 (en)1982-12-16
IE50806B1 (en)1986-07-23
SE447450B (en)1986-11-17
FI810056L (en)1981-07-12
AU6597681A (en)1981-07-16
AT374681B (en)1984-05-25
DE3100191C2 (en)1988-09-01
JPS56103110A (en)1981-08-18
CH646604A5 (en)1984-12-14
ES8301629A1 (en)1982-12-16
NZ195933A (en)1982-11-23
IT8147537A0 (en)1981-01-09
IN151913B (en)1983-09-03
ES8205353A1 (en)1982-06-01
IT1221041B (en)1990-06-21
FR2473308B1 (en)1985-07-19
NO810062L (en)1981-07-13
DK6181A (en)1981-07-12
BE886998A (en)1981-07-08
ATA5481A (en)1983-10-15
ES498369A0 (en)1982-06-01
NO156153B (en)1987-04-27
FI76927B (en)1988-09-30
ZA81136B (en)1982-01-27
FI76927C (en)1989-01-10
GB2067072A (en)1981-07-22
LU83052A1 (en)1982-09-10
GB2067072B (en)1983-08-10
AU542824B2 (en)1985-03-14
DE3100191A1 (en)1981-12-10
NL8100037A (en)1981-08-03
IE810036L (en)1981-07-11
FR2473308A1 (en)1981-07-17

Similar Documents

PublicationPublication DateTitle
FR2474309B1 (en)
FR2496811B1 (en)
FR2474136B1 (en)
FR2474101B1 (en)
FR2474195B1 (en)
FR2473037B1 (en)
IN151913B (en)
FR2473431B1 (en)
FR2473488B1 (en)
FR2473733B1 (en)
FR2473436B1 (en)
FR2472958B1 (en)
FR2473561B1 (en)
FR2473924B1 (en)
FR2474255B1 (en)
FR2486947B1 (en)
FR2473532B1 (en)
FR2473189B1 (en)
FR2472970B1 (en)
FR2474357B1 (en)
FR2473456B3 (en)
FR2473586B1 (en)
FR2474284B1 (en)
FR2474227B1 (en)
FR2474115B1 (en)

[8]ページ先頭

©2009-2025 Movatter.jp